Different roles of dexamethasone on transforming growth factor-beta1-induced fibronectin and nerve growth factor expression in dental pulp cells

J Endod. 2007 Sep;33(9):1057-60. doi: 10.1016/j.joen.2007.05.007. Epub 2007 Jul 5.

Abstract

During pulp injury, it has been hypothesized that transforming growth factor-beta1 (TGF-beta1) is released from dentin into pulp tissue and promotes pulp tissue healing. Dexamethasone is a glucocorticoid that has been used to treat pulp injury and shown to induce differentiation of hard tissue forming cells. However, the interaction between dexamethasone and TGF-beta1 is still unknown. This study aimed to examine the effects of dexamethasone on human pulp cells in the presence of TGF-beta1. TGF-beta1 increased expression and synthesis of both fibronectin and nerve growth factor (NGF), whereas dexamethasone stimulated fibronectin synthesis but inhibited NGF expression. The application of both TGF-beta1 and dexamethasone resulted in an additional effect on fibronectin; however, dexamethasone inhibited the TGF-beta1-induced NGF expression. Dexamethasone promotes fibronectin synthesis and suppresses NGF secretion, suggesting that this reagent could be used clinically to reduce pain and promote dental pulp tissue healing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / pharmacology*
  • Dental Pulp / cytology
  • Dental Pulp / drug effects*
  • Dexamethasone / pharmacology*
  • Fibronectins / drug effects*
  • Humans
  • Intracellular Signaling Peptides and Proteins / metabolism
  • LIM Domain Proteins
  • Nerve Growth Factor / drug effects*

Substances

  • Anti-Inflammatory Agents
  • Fibronectins
  • Intracellular Signaling Peptides and Proteins
  • LIM Domain Proteins
  • TGFB1I1 protein, human
  • Dexamethasone
  • Nerve Growth Factor